Effect of Cardiotonic Steroid Marinobufagenin on Vascular Remodeling and Cognitive Impairment in Young Dahl-S Rats

The hypertensive response in Dahl salt-sensitive (DSS) rats on a high-salt (HS) diet is accompanied by central arterial stiffening (CAS), a risk factor for dementia, and heightened levels of a prohypertensive and profibrotic factor, the endogenous Na/K-ATPase inhibitor marinobufagenin (MBG). We studied the effect of the in vivo administration of MBG or HS diet on blood pressure (BP), CAS, and behavioral function in young DSS rats and normotensive Sprague–Dawley rats (SD), the genetic background for DSS rats. Eight-week-old male SD and DSS rats were given an HS diet (8% NaCl, n = 18/group) or a low-salt diet (LS; 0.1% NaCl, n = 14–18/group) for 8 weeks or MBG (50 µg/kg/day, n = 15–18/group) administered via osmotic minipumps for 4 weeks in the presence of the LS diet. The MBG-treated groups received the LS diet. The systolic BP (SBP); the aortic pulse wave velocity (aPWV), a marker of CAS; MBG levels; spatial memory, measured by a water maze task; and tissue collection for the histochemical analysis were assessed at the end of the experiment. DSS-LS rats had higher SBP, higher aPWV, and poorer spatial memory than SD-LS rats. The administration of stressors HS and MBG increased aPWV, SBP, and aortic wall collagen abundance in both strains vs. their LS controls. In SD rats, HS or MBG administration did not affect heart parameters, as assessed by ECHO vs. the SD-LS control. In DSS rats, impaired whole-heart structure and function were observed after HS diet administration in DSS-HS vs. DSS-LS rats. MBG treatment did not affect the ECHO parameters in DSS-MBG vs. DSS-LS rats. The HS diet led to an increase in endogenous plasma and urine MBG levels in both SD and DSS groups. Thus, the prohypertensive and profibrotic effect of HS diet might be partially attributed to an increase in MBG. The prohypertensive and profibrotic functions of MBG were pronounced in both DSS and SD rats, although quantitative PCR revealed that different profiles of profibrotic genes in DSS and SD rats was activated after MBG or HS administration. Spatial memory was not affected by HS diet or MBG treatment in either SD or DSS rats. Impaired cognitive function was associated with higher BP, CAS, and cardiovascular remodeling in young DSS-LS rats, as compared to young SD-LS rats. MBG and HS had similar effects on the cardiovascular system and its function in DSS and SD rats, although the rate of change in SD rats was lower than in DSS rats. The absence of a cumulative effect of increased aPWV and BP on spatial memory can be explained by the cerebrovascular and brain plasticity in young rats, which help the animals to tolerate CAS elevated by HS and MBG and to counterbalance the profibrotic effect of heightened MBG.

[1]  B. Barres,et al.  Neurotoxic reactive astrocytes induce cell death via saturated lipids , 2021, Nature.

[2]  R. Moretti,et al.  From Brain to Heart: Possible Role of Amyloid-β in Ischemic Heart Disease and Ischemia-Reperfusion Injury , 2020, International journal of molecular sciences.

[3]  O. Fedorova,et al.  Na+, K+-ATPase α Isoforms and Endogenous Cardiac Steroids in Prefrontal Cortex of Bipolar Patients and Controls , 2020, International journal of molecular sciences.

[4]  E. Lakatta,et al.  Cardiotonic steroids induce vascular fibrosis via pressure-independent mechanism in NaCl-loaded diabetic rats. , 2019, Journal of cardiovascular pharmacology.

[5]  E. Lakatta,et al.  Monoclonal Antibody to Marinobufagenin Downregulates TGFβ Profibrotic Signaling in Left Ventricle and Kidney and Reduces Tissue Remodeling in Salt‐Sensitive Hypertension , 2019, Journal of the American Heart Association.

[6]  Max I Bogorad,et al.  Cerebrovascular plasticity: Processes that lead to changes in the architecture of brain microvessels , 2019, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[7]  M. Piras,et al.  Cardiac Abnormalities in Alzheimer Disease: Clinical Relevance Beyond Pathophysiological Rationale and Instrumental Findings? , 2019, JACC. Heart failure.

[8]  A. Schutte,et al.  Large artery stiffness is associated with marinobufagenin in young adults: the African-PREDICT study , 2018, Journal of hypertension.

[9]  E. Lakatta,et al.  Dietary Sodium Restriction Reduces Arterial Stiffness, Vascular TGF-β-Dependent Fibrosis and Marinobufagenin in Young Normotensive Rats , 2018, International journal of molecular sciences.

[10]  Qian Zhao,et al.  Association between ApoE polymorphism and hypertension: A meta-analysis of 28 studies including 5898 cases and 7518 controls. , 2018, Gene.

[11]  M. Stecker,et al.  Amyloid toxicity in Alzheimer’s disease , 2018, Reviews in the neurosciences.

[12]  O. Fedorova,et al.  Marinobufagenin and left ventricular mass in young adults: The African-PREDICT study , 2018, European journal of preventive cardiology.

[13]  R. V. Manalo.  Molecular interactions with redox sites and salt bridges modulate the anti-aggregatory effect of flavonoid, tannin and cardenolide moieties against amyloid-beta (1–42) in silico , 2017, In Silico Pharmacology.

[14]  Jayeeta Basu,et al.  Hippocampal function in rodents , 2017, Current Opinion in Neurobiology.

[15]  K. Khodosevich,et al.  Neuronal survival in the brain: neuron type-specific mechanisms , 2017, Cell Death & Disease.

[16]  N. Zheleznova,et al.  Role of Nox4 and p67phox subunit of Nox2 in ROS production in response to increased tubular flow in the mTAL of Dahl salt-sensitive rats. , 2016, American journal of physiology. Renal physiology.

[17]  L. Kaltenbach,et al.  Dual activities of the anti-cancer drug candidate PBI-05204 provide neuroprotection in brain slice models for neurodegenerative diseases and stroke , 2016, Scientific Reports.

[18]  E. Lakatta,et al.  Aortic Fibrosis, Induced by High Salt Intake in the Absence of Hypertensive Response, is Reduced by a Monoclonal Antibody to Marinobufagenin. , 2016, American Journal of Hypertension.

[19]  V. Herrera,et al.  Sex-specific genetic determinants for arterial stiffness in Dahl salt-sensitive hypertensive rats , 2016, BMC Genetics.

[20]  E. Lakatta,et al.  Synthesis of an Endogenous Steroidal Na Pump Inhibitor Marinobufagenin, Implicated in Human Cardiovascular Diseases, Is Initiated by CYP27A1 via Bile Acid Pathway , 2015, Circulation. Cardiovascular genetics.

[21]  E. Lakatta,et al.  Marinobufagenin-induced vascular fibrosis is a likely target for mineralocorticoid antagonists , 2015, Journal of hypertension.

[22]  P. Dabla,et al.  Oxidative stress and antioxidants in hypertension-a current review. , 2015, Current hypertension reviews.

[23]  M. Gallagher,et al.  A fine balance: Regulation of hippocampal Arc/Arg3.1 transcription, translation and degradation in a rat model of normal cognitive aging , 2014, Neurobiology of Learning and Memory.

[24]  V. Herrera,et al.  Aortic and Carotid Arterial Stiffness and Epigenetic Regulator Gene Expression Changes Precede Blood Pressure Rise in Stroke-Prone Dahl Salt-Sensitive Hypertensive Rats , 2014, PloS one.

[25]  Q. Jia,et al.  Anti-Inflammatory and Antinociceptive Activities of Bufalin in Rodents , 2014, Mediators of inflammation.

[26]  Bradley S. Fleenor,et al.  Dietary sodium restriction and association with urinary marinobufagenin, blood pressure, and aortic stiffness. , 2013, Clinical journal of the American Society of Nephrology : CJASN.

[27]  H. Monyer,et al.  Connective Tissue Growth Factor Regulates Interneuron Survival and Information Processing in the Olfactory Bulb , 2013, Neuron.

[28]  C. Combs,et al.  Expression and function of APP and its metabolites outside the central nervous system , 2013, Experimental Gerontology.

[29]  E. Lakatta,et al.  Chronic Administration of Small Nonerythropoietic Peptide Sequence of Erythropoietin Effectively Ameliorates the Progression of Postmyocardial Infarction–Dilated Cardiomyopathy , 2013, The Journal of Pharmacology and Experimental Therapeutics.

[30]  H. Jacob,et al.  Identification of Hypertension Susceptibility Loci on Rat Chromosome 12 , 2012, Hypertension.

[31]  C. Xiao,et al.  Novel genes as primary triggers for polygenic hypertension , 2012, Journal of hypertension.

[32]  J. C. de la Torre.  Cerebral hemodynamics and vascular risk factors: setting the stage for Alzheimer's disease. , 2012, Journal of Alzheimer's disease : JAD.

[33]  J. Zicha,et al.  Age-dependent salt hypertension in Dahl rats: fifty years of research. , 2012, Physiological research.

[34]  S. Haller,et al.  Endogenous cardiotonic steroids in chronic renal failure. , 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[35]  S. Black,et al.  Vascular Contributions to Cognitive Impairment and Dementia: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association , 2011, Stroke.

[36]  Mingyu Liang,et al.  Narrowing a region on rat chromosome 13 that protects against hypertension in Dahl SS-13BN congenic strains. , 2011, American journal of physiology. Heart and circulatory physiology.

[37]  H. Kobori,et al.  Blockade of AT1 receptors protects the blood-brain barrier and improves cognition in Dahl salt-sensitive hypertensive rats. , 2011, American journal of hypertension.

[38]  J. Shapiro,et al.  Endogenous cardiotonic steroids and salt-sensitive hypertension. , 2010, Biochimica et biophysica acta.

[39]  Xianlin Han.  The Pathogenic Implication of Abnormal Interaction Between Apolipoprotein E Isoforms, Amyloid-beta Peptides, and Sulfatides in Alzheimer’s Disease , 2010, Molecular Neurobiology.

[40]  O. Fedorova,et al.  Endogenous cardiotonic steroids and differential patterns of sodium pump inhibition in NaCl-loaded salt-sensitive and normotensive rats. , 2009, American journal of hypertension.

[41]  D. Watson,et al.  Marinobufagenin induces increases in procollagen expression in a process involving protein kinase C and Fli-1: implications for uremic cardiomyopathy. , 2009, American journal of physiology. Renal physiology.

[42]  Y. Asano,et al.  Phosphorylation of Fli1 at Threonine 312 by Protein Kinase C δ Promotes Its Interaction with p300/CREB-Binding Protein-Associated Factor and Subsequent Acetylation in Response to Transforming Growth Factor β , 2009, Molecular and Cellular Biology.

[43]  E. Lakatta,et al.  Monoclonal antibody to an endogenous bufadienolide, marinobufagenin, reverses preeclampsia-induced Na/K-ATPase inhibition and lowers blood pressure in NaCl-sensitive hypertension , 2008, Journal of hypertension.

[44]  G. Mitchell.  Effects of central arterial aging on the structure and function of the peripheral vasculature: implications for end-organ damage. , 2008, Journal of applied physiology.

[45]  C. Iadecola,et al.  Hypertension and cerebrovascular dysfunction. , 2008, Cell metabolism.

[46]  Larisa V. Fedorova,et al.  Marinobufagenin Stimulates Fibroblast Collagen Production and Causes Fibrosis in Experimental Uremic Cardiomyopathy , 2007, Hypertension.

[47]  H. Ovadia,et al.  Involvement of Na+, K+-ATPase and Endogenous Digitalis-Like Compounds in Depressive Disorders , 2006, Biological Psychiatry.

[48]  R. Martins,et al.  Apolipoprotein E, cholesterol metabolism, diabetes, and the convergence of risk factors for Alzheimer's disease and cardiovascular disease , 2006, Molecular Psychiatry.

[49]  O. Krizanova,et al.  Is the ApoE polymorphism associated with dilated cardiomyopathy? , 2006, General physiology and biophysics.

[50]  Deepak Malhotra,et al.  Central Role for the Cardiotonic Steroid Marinobufagenin in the Pathogenesis of Experimental Uremic Cardiomyopathy , 2006, Hypertension.

[51]  C. Iadecola,et al.  Neurovascular coupling in the normal brain and in hypertension, stroke, and Alzheimer disease. , 2006, Journal of applied physiology.

[52]  O. Fedorova,et al.  Endogenous digitalis-like ligands and Na/K-ATPase inhibition in experimental diabetes mellitus. , 2005, Frontiers in bioscience : a journal and virtual library.

[53]  B. Winblad,et al.  The age-dependent relation of blood pressure to cognitive function and dementia , 2005, The Lancet Neurology.

[54]  D. Ganten,et al.  Identification of Hypertension-Related Genes Through an Integrated Genomic-Transcriptomic Approach , 2005, Circulation research.

[55]  J. Tonkiss,et al.  Modulation of Learning and Memory in Dahl Rats by Dietary Salt Restriction , 2004, Hypertension.

[56]  M. Hori,et al.  AT1 Receptor Blocker Added to ACE Inhibitor Provides Benefits at Advanced Stage of Hypertensive Diastolic Heart Failure , 2004, Hypertension.

[57]  J. Tonkiss,et al.  X-linked loci influence spatial navigation performance in Dahl rats. , 2004, Physiological genomics.

[58]  E. Masliah,et al.  Loss of TGF-β1 Leads to Increased Neuronal Cell Death and Microgliosis in Mouse Brain , 2003, Neuron.

[59]  E. Jaimes,et al.  In Salt-Sensitive Hypertension, Increased Superoxide Production Is Linked to Functional Upregulation of Angiotensin II , 2003, Hypertension.

[60]  M. Garrett,et al.  Time-course genetic analysis of albuminuria in Dahl salt-sensitive rats on low-salt diet. , 2003, Journal of the American Society of Nephrology : JASN.

[61]  R. D'Hooge,et al.  Age‐dependent cognitive decline in the APP23 model precedes amyloid deposition , 2003, The European journal of neuroscience.

[62]  E. Zvartau,et al.  Marinobufagenin (MBG) suppression of ethanol-seeking behavior is associated with inhibition of brain cortex Na/K-ATPase in mice , 2002, European Neuropsychopharmacology.

[63]  D. Royall,et al.  Alzheimer disease as a vascular disorder: nosological evidence. , 2002, Stroke.

[64]  E. Lakatta,et al.  Endogenous Ligand of &agr;1 Sodium Pump, Marinobufagenin, Is a Novel Mediator of Sodium Chloride–Dependent Hypertension , 2002, Circulation.

[65]  J. Buccafusco,et al.  Dahl salt-sensitive and salt-resistant rats: examination of learning and memory performance, blood pressure, and the expression of central nicotinic acetylcholine receptors , 2001, Neuroscience.

[66]  E. Lakatta,et al.  Marinobufagenin, an endogenous alpha-1 sodium pump ligand, in hypertensive Dahl salt-sensitive rats. , 2001, Hypertension.

[67]  E. Lakatta,et al.  Endogenous Na,K Pump Ligands Are Differentially Regulated During Acute NaCl Loading of Dahl Rats , 2000, Circulation.

[68]  M. Hori,et al.  Development of different phenotypes of hypertensive heart failure: systolic versus diastolic failure in Dahl salt‐sensitive rats , 2000, Journal of hypertension.

[69]  O. Fedorova,et al.  Circulating bufodienolide and cardenolide sodium pump inhibitors in preeclampsia. , 1999, Journal of hypertension.

[70]  L. Chao,et al.  Atrial natriuretic peptide gene delivery reduces stroke-induced mortality rate in Dahl salt-sensitive rats. , 1999, Hypertension.

[71]  N. Hirawa,et al.  The implication of renin-angiotensin system on renal injury seen in Dahl salt-sensitive rats. , 1997, American journal of hypertension.

[72]  L. Havekes,et al.  Severe learning deficits in apolipoprotein E-knockout mice in a water maze task , 1997, Brain Research.

[73]  D. Michaelson,et al.  Biochemical and cognitive studies of apolipoprotein-E-deficient mice , 1996, Molecular and chemical neuropathology.

[74]  A. Mark,et al.  Genetic characterization of the "new" Harlan Sprague Dawley Dahl salt-sensitive rats. , 1996, Hypertension.

[75]  U. Hopfer,et al.  Pathophysiological consequences of changes in the coupling ratio of Na,K-ATPase for renal sodium reabsorption and its implications for hypertension. , 1996, Hypertension.

[76]  R. Havlik,et al.  The association between midlife blood pressure levels and late-life cognitive function. The Honolulu-Asia Aging Study. , 1995, JAMA.

[77]  S Sasayama,et al.  Transition from compensatory hypertrophy to dilated, failing left ventricles in Dahl salt-sensitive rats. , 1994, The American journal of physiology.

[78]  J. Laragh,et al.  Angiotensin II receptor antagonist delays renal damage and stroke in salt-loaded Dahl salt-sensitive rats. , 1992, Journal of hypertension.

[79]  R. Roman,et al.  Role of blood volume expansion in Dahl rat model of hypertension. , 1990, The American journal of physiology.

[80]  B. Rayson.  Na+/K+-ATPase regulation in Dahl salt-sensitive and salt-resistant rats. , 1988, The Journal of biological chemistry.

[81]  D. Ganten,et al.  Renal disease and the development of hypertension in salt-sensitive Dahl rats. , 1988, Kidney international.

[82]  L. Tassinari,et al.  Effects of Chronic Excess Salt Ingestion: Vascular Reactivity in Two Strains of Rats with Opposite Genetic Susceptibility to Experimental Hypertension , 1964, Circulation.

[83]  L. Dahl,et al.  EFFECTS OF CHRONIC EXCESS SALT INGESTION: EXPERIMENTAL HYPERTENSION IN THE RAT. , 1964, Canadian Medical Association journal.

[84]  LEWIS K. DAHL,et al.  Role of Genetic Factors in Susceptibility to Experimental Hypertension due to Chronic Excess Salt Ingestion , 1962, Nature.